SCHEMBL8973208

SCHEMBL8973208

Cc1ccc2ccc(S(=O)(=O)N3CC(=O)NC3=O)cc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
HSD17B10 Q99714 3/20 0.49
TSHR P16473 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
USP2 O75604 1/20 0.49
HPGD P15428 1/20 0.49
MAPK1 P28482 1/20 0.49
MMP2 P08253 1/20 0.45
LMNA P02545 1/20 0.42
PKM P14618 1/20 0.42
HTT P42858 1/20 0.42
KDM2B Q8NHM5 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
POLB P06746 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2A6 P11509 1/20 0.39
MAPT P10636 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CA1 P00915 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8973411 0.84 PKM (0.52) ALDH1A1HSD17B10TSHRSMN1; SMN2LMNA
SCHEMBL10594253 0.84 MMP2 (0.64) ALDH1A1HSD17B10SMN1; SMN2MMP2PKM
SCHEMBL8973126 0.83 MEN1 (0.50) ALDH1A1HSD17B10SMN1; SMN2MMP2KDM2B
SCHEMBL8973637 0.79 MMP2 (0.46) ALDH1A1HSD17B10MMP2PKMTDP1
SCHEMBL8973357 0.79 MEN1 (0.51) ALDH1A1HSD17B10MMP2KDM2BTDP1
SCHEMBL8800496 0.76 SMN1; SMN2 (0.57) ALDH1A1SMN1; SMN2PKMHTTMEN1
SCHEMBL8973311 0.76 ALDH1A1 (0.44) ALDH1A1HSD17B10SMN1; SMN2LMNAPKM
SCHEMBL8973603 0.72 TDP1 (0.45) ALDH1A1HSD17B10TSHRSMN1; SMN2MAPK1
SCHEMBL8973561 0.72 HTR6 (0.47) ALDH1A1HSD17B10MMP2PKMTDP1
SCHEMBL10680095 0.72 HSD17B10 (0.42) ALDH1A1HSD17B10TSHRMMP2PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0444546-B1 Hydantoin derivatives for use as hypoglycemic and/or hypolipidemic agents MOCHIDA PHARM CO LTD (JP) 1996-09-11 EP disclosed
US-RE35279-E ALDOSE REDUCTASE INHIBITORS MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1996-06-18 US disclosed
US-5202339-A Hypoglycemic, hypolipedemic agents MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1993-04-13 US disclosed
EP-0305947-B1 HYDANTOIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS WELL AS THEIR USE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1992-07-29 EP disclosed
WO-1991012803-A1 HYDANTOIN DERIVATIVES FOR USE AS HYPOGLYCEMIC AND/OR HYPOLIPIDEMIC AGENTS MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1991-09-05 WO disclosed
EP-0444546-A1 Hydantoin derivatives for use as hypoglycemic and/or hypolipidemic agents MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1991-09-04 EP disclosed
US-5004751-A Antidiabetic agents; aldoe reductase inhibitors MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1991-04-02 US disclosed
US-4914099-A TREATMENT OR PREVENTION OF DIABETIC COMPLICATIONS MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1990-04-03 US disclosed
WO-1989001934-A1 HYDANTOIN DERIVATIVES MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1989-03-09 WO disclosed
EP-0305947-A1 Hydantoin derivatives, process for their preparation and pharmaceutical compositions containing the same as well as their use MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1989-03-08 EP disclosed